ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.

However, only a nonsignificant trend was observed when analyzing GBM separately in the TCGA dataset, suggesting that the prognostic impact of ELTD1 is more pronounced in tumors where there is a higher variance in the extent of vascular abnormality. 7 This discrepancy may also be due to differences in sample acquisition.

also in 5,406 other papers